Wang et al. showed that overexpression of this miRNA in AML cell lines reduced both mRNA and cell surface protein expression of PD-L1, an inhibitory immune checkpoint molecule, suggesting the potential role of miR-34a mimic also in AML immunotherapy [68]. This evidence concerns the gene CD274 and acute myeloid leukemia.